Physician profile
Heather Geyman
NPI 1013737394
$1,770.51
in general payments reported to CMS, 2019-2025
21 companies · $1,637 in 2025
The $1,637 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $133 · 2025: $1,637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,770.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $314.19 | 2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $303.60 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $245.35 | 2025 | Breztri, Airsupra, Farxiga |
| Amgen INC. | $143.74 | 2025 | Evenity, Otezla, Repatha |
| Edwards Lifesciences Corporation | $142.63 | 2025 | Sapien 3 Ultra Resilia |
| Astellas Pharma US INC | $130.69 | 2025 | Veozah |
| Radius Health, INC. | $78.74 | 2025 | Tymlos |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $74.43 | 2025 | Xifaxan |
| Recordati_rare_diseases_inc. | $68.86 | 2025 | Isturisa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.10 | 2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $32.85 | 2025 | |
| Lilly USA, LLC | $29.17 | 2025 | Zepbound, Mounjaro |
| Kyowa Kirin, INC. | $28.36 | 2025 | |
| Corcept Therapeutics | $24.96 | 2025 | Korlym |
| Sumitomo Pharma America, INC. | $20.62 | 2025 | Gemtesa |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.96 | 2025 | Caplyta |
| Exact Sciences Corporation | $17.48 | 2025 | The Cologuard Plus Collection Kit |
| Aimmune Therapeutics, INC. | $16.97 | 2025 | Zenpep |
| Inspire Medical Systems, INC. | $16.17 | 2024 | Inspire |
| Abbott Laboratories | $14.75 | 2025 | Proclaim |
| Takeda Pharmaceuticals U.S.A., INC. | $13.89 | 2025 | Trintellix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Geyman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.